Biotech

Former Credit Suisse CEO has Human Longevity investment in his sights

Biotech

Smart drug delivery system to treat multiple Alzheimer’s pathologies bags $2.4m funding

Biotech

James Kirkland: Senolytics have a 20% chance of success

Mayo Clinic scientist who discovered senolytic drugs is more optimistic than ever that the field will produce positive results in humans.
Biotech

Industrially significant Alzheimer’s drug trial results warrant cautious excitement

Biotech

Cleara Biotech closes $2.5m seed financing to advance senotherapeutics

Biotech

Halberd enters strategic alliance for longevity and Alzheimer’s disease

Biotech

Biomanufacturing to reduce the cost of regenerative medicine

Biotech

Phase 3 trial shows Alzheimer’s drug slows progression of disease

Biotech

Eye-level longevity – why breakthrough research is top investment opportunity

Biotech

We might not know the future… but we can spot its longevity trends and drivers

Biotech

Taking the longevity field one step beyond

Biotech

Ian White: “We’re right on the precipice of fundamental changes in longevity research”

Biotech

“At the cutting edge of longevity research”

Biotech

Cellvie – unlocking the power of cell-derived medicines

Biotech

Alector initiates Phase 1 clinical trial for treatment of Alzheimer’s

Biotech

Pretzel Therapeutics launches with $72.5m Series A to pioneer mitochondrial therapies

Biotech

Organicell bags additional $11 million financing in preparation for clinical trial enrolment

Biotech

NaNotics to collaborate with Mass General Cancer Center on novel nanomedicine

Biotech

Preclinical biotech Lento Bio raises $680,000 in oversubscribed seed round

Biotech

£1.1m funding for world’s first needle-free continuous glucose monitor

Biotech

‘Polypill’ reduces cardiovascular mortality by 33% in patients treated after a heart attack

Biotech

Putting autophagy front and centre in longevity drug development

Biotech

New drug set to expand treatment options for rheumatoid arthritis

Biotech

Regenerative medicine is now ready to drive longevity forward

Biotech

CELLINK and IISc collaborate to advance research in 3D bioprinting

Biotech

Remedium Bio closes successful $2.3m expanded seed raise

Biotech

UNITY Biotech doubles share price after positive data for diabetes-related vision loss drug

Biotech

Christian Angermayer on longevity and biotech investment: it’s bouncing back

Biotech

Building precision nutritional intervention from the ground up

Biotech

Researchers discover new molecules with longevity boosting potential

Biotech

Loss of male sex chromosome leads to shortened longevity for men

Biotech

Stem cells, longevity and the final frontier

Biotech